|
See related Viread film-coated tab information |
|
|
|
Manufacturer |
Gilead Sciences |
|
Distributor |
Hong Kong: LF Asia |
|
Contents |
Tenofovir disoproxil fumarate |
|
Indications |
Treatment of HIV-1 infection in combination w/ other antiretroviral agents. Treatment of chronic hepatitis B infection in adults.
Click to view Viread detailed prescribing infomation |
|
Dosage |
1 tab once daily.
Click to view Viread detailed prescribing infomation |
|
Overdosage |
View Viread overdosage for action to be taken in the event of an overdose. |
|
Administration |
May be taken with or without food (Take consistently either always w/ or always w/o food.). |
|
Contraindications |
Hypersensitivity. Lactation.
Click to view Viread detailed prescribing infomation |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Viread detailed prescribing infomation |
|
Special Precautions |
Lactic acidosis/severe hepatomegaly w/ steatosis (discontinue); HIV & HBV coinfection; history or present renal dysfunction. Concurrent treatment w/ nephrotoxic agents. Monitor bone esp patients w/ history of pathologic bone fracture or at risk for osteopenia. Body fat re-distribution/accumulation; immune reconstitution syndrome. Pregnancy. Elderly, childn <18 yr.
Click to view Viread detailed prescribing infomation |
|
Adverse Drug Reactions |
Asthenia, pain, headache, abdominal pain, back pain, chest pain, fever; diarrhea, nausea, vomiting, anorexia, dyspepsia, flatulence, pneumonia; depression, insomnia, peripheral neuropathy, dizziness; rash, sweating, myalgia; wt loss; allergic reaction; increased amylase, pancreatitis; increased liver enzymes, hepatitis; renal & urinary disorders.
View ADR Monitoring Form |
|
Drug Interactions |
Didanosine, atazanavir, lopinavir/ritonavir, adefovir dipivoxil, cidofovir, acyclovir, valacyclovir, ganciclovir, valganciclovir & tenofovir.
View more drug interactions with Viread |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view Viread detailed prescribing infomation |
|
Storage |
View Viread storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Viread description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Viread mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
ATC Classification |
J05AF07 - tenofovir disoproxil ; Belongs to the class of nucleoside and nucleotide reverse transcriptase inhibitors. Used in the systemic treatment of viral infections. |
